Effects of tVNS and mCIMT in Chronic Stroke
Recruiting
N/A
Interventional Study
Stroke
Cerebrovascular Accident
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Riphah International University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Stroke is a leading cause of death and disability worldwide, resulting in significant physical and cognitive impairments. Arm weakness is most common after stroke and its treatment is recognized as an area of considerable need. The functional limitations and disabilities experienced by stroke survivors, particularly in the upper limb have a profound impact on their quality of life. Current treatme…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Both male and female patients are included in the study.
* Left sided ischemic stroke patients.
* Patients with chronic, moderate-severe upper limb hemiparesis (\>6 months-2 years)
* Stable participants having a stroke severity score \> 6 on National Institute of Health Stroke…
Contacts